Forest Investigative Site 202 — Richmond, Virginia

Forest Investigative Site 202 is a clinical research site located in Richmond, Virginia, United States 23225.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 202 has participated in 1 clinical trials.

Therapeutic areas: COPD, COPD Exacerbation, Lung Diseases.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Richmond

Browse all research sites in Virginia · View every site in Richmond

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 202?

Forest Investigative Site 202 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 202 conducted?

Forest Investigative Site 202 has 1 clinical trials on record. Their work covers COPD, COPD Exacerbation, Lung Diseases.

Is Forest Investigative Site 202 accredited by Crixeo Clinical Trials?

Forest Investigative Site 202 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 202?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.